PGAP2 (Gene)

Organism:

Homo sapiens

Synonyms:CWH43-N, ENTREZ:27315, FRAG1, HGNC:17893, HPMRS3, MIM:615187, MRT17, MRT21, NM_001145438, NM_001256235, NM_001256236, NM_001256237, NM_001256238, NM_001256239, NM_001256240, NM_001283038, NM_001283039, NM_001283040, NM_001346397, NM_001346398, NM_001346399, NM_001346400, NM_001346401, NM_001346402, NM_001346403, NM_001346404, NM_001346405, NM_014489, NP_001138910, NP_001243164, NP_001243165, NP_001243166, NP_001243167, NP_001243168, NP_001243169, NP_001269967, NP_001269968, NP_001269969, NP_001333326, NP_001333327, NP_001333328, NP_001333329, NP_001333330, NP_001333331, NP_001333332, NP_001333333, NP_001333334, NP_055304, NR_027016, NR_027017, NR_027018, NR_045923, NR_045925, NR_045926, NR_045927, NR_045929, NR_104270, NR_104271, NR_104272, NR_144427, NR_144428, NR_144429, NR_144430, PGAP2, XM_006718181, XM_006718185, XM_006718186, XM_006718190, XM_006718191, XM_006718193, XM_011519990, XM_011519991, XM_011519992, XM_011519994, XM_011519996, XM_011519997, XM_011519998, XM_011519999, XM_011520002, XM_011520003, XM_011520004, XM_011520006, XM_011520007, XM_017017558, XM_017017559, XM_017017560, XM_024448442, XM_024448443, XM_024448444, XM_024448445, XM_024448446, XP_006718244, XP_006718248, XP_006718249, XP_006718253, XP_006718254, XP_006718256, XP_011518292, XP_011518293, XP_011518294, XP_011518296, XP_011518298, XP_011518299, XP_011518300, XP_011518301, XP_011518304, XP_011518305, XP_011518306, XP_011518308, XP_011518309, XP_016873047, XP_016873048, XP_016873049, XP_024304210, XP_024304211, XP_024304212, XP_024304213, XP_024304214, post-GPI attachment to proteins 2

Omim:OMIM:615187

Id:ENSG00000148985

Hgnc:HGNC:17893

Entrez:27315

Ensembl:ENSG00000148985

Description:post-GPI attachment to proteins 2

The protein encoded by this gene plays a role in the maturation of glycosylphosphatidylinositol (GPI) anchors on GPI-anchored proteins. Mutations in this gene are associated with an autosomal recessive syndrome characterized by hyperphosphatasia and intellectual disability. [provided by RefSeq, Jul 2017]

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View PGAP2's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with PGAP2.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using PGAP2.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for PGAP2.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with PGAP2.

Results found

Linked to

	Label	Description
	GSE228727 2 V 1 DAPAGLIFLOZIN MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE138789 metformin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE197555 0 V 3 TRAMETINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE200982 PLAC8 knockout 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 1 V 2 AMILORIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 8 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE158456 2 V 3 FURIN MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE158431 2 V 0 PIOGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 8 V 1 SULFORAPHANE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE119369 H10 inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS